Showing results (1-10 of 211) with videos related to
Sort By:
Pageof 22
Frontiers in Immunology|December 6, 2021
Immune Dysregulation and Infectious Complications in MPN Patients Treated With JAK InhibitorsDaniele Cattaneo, Alessandra IurloClinical Medicine Insights. Blood Disorders|June 6, 2017
Treatment of Myelofibrosis: Old and New StrategiesAlessandra Iurlo, Daniele CattaneoBlood Reviews|September 24, 2022
Biologic therapies for hypereosinophilic disorders: From tyrosine kinase inhibitors to monoclonal antibodies. Towards an increasingly customized management?Alessandra Iurlo, Daniele CattaneoCurrent Treatment Options in Oncology|May 1, 2020
Management of Myelofibrosis: from Diagnosis to New Target TherapiesAlessandra Iurlo, Daniele Cattaneo, Cristina BucelliExpert Review of Hematology|October 8, 2019
Hypereosinophilic syndromes in the precision medicine era: clinical, molecular aspects and therapeutic approaches (targeted therapies)Alessandra Iurlo, Daniele Cattaneo, Umberto GianelliInternational Journal of Molecular Sciences|April 25, 2019
Blast Transformation in Myeloproliferative Neoplasms: Risk Factors, Biological Findings, and Targeted Therapeutic OptionsAlessandra Iurlo, Daniele Cattaneo, Umberto GianelliCurrent Treatment Options in Oncology|May 17, 2023
Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical NeedsAlessandra Iurlo, Cristina Bucelli, Daniele CattaneoLeukemia & Lymphoma|February 17, 2025
<i>CALR</i>-mutated myeloproliferative neoplasmsValentina Bellani, Barbara Mora, Alessandra Iurlo, et al.Hemasphere|December 11, 2025
Atypical chronic myeloid leukemia: From diagnosis to molecular features and therapeutic optionsAlessandra Iurlo, Daniele Cattaneo, Umberto Gianelli, et al.Journal of Clinical Medicine|February 4, 2021
Dose Optimization of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A New Therapeutic ChallengeAlessandra Iurlo, Daniele Cattaneo, Cristina Bucelli, et al.Pageof 22